inclusion criteria: * laboratory confirmed diagnosis of infection with sars-cov-2 * symptoms of covid -19 - cough, fever, sore throat, sob, anosmia, diarrhea, myalgia * symptoms less than 14 days * id physician determination that the patient does not need hospitalization * o2 saturation of \>93% * informed consent provided by the patient or healthcare proxy * age ≥ 18 years * ambulatory outpatient when informed consent obtained and study drug is administered

inclusion criteria: * laboratory confirmed diagnosis of infection with sars-cov-2 * symptoms of covid -19 - cough, fever, sore throat, sob, anosmia, diarrhea, myalgia * symptoms less than 14 days * id physician determination that the patient does not need hospitalization * o2 saturation of \>93% * informed consent provided by the patient or healthcare proxy * age ≥ 18 years * ambulatory outpatient when informed consent obtained and study drug is administered

inclusion criteria: - laboratory confirmed diagnosis of infection with sars-cov-2 - symptoms of covid -19 - cough, fever, sore throat, sob, anosmia, diarrhea, myalgia - symptoms less than 14 days - id physician determination that the patient does not need hospitalization - o2 saturation of >93% - informed consent provided by the patient or healthcare proxy - age ≥ 18 years - ambulatory outpatient when informed consent obtained and study drug is administered

inclusion criteria: - laboratory confirmed diagnosis of infection with sars-cov-2 - symptoms of covid -19 - cough, fever, sore throat, sob, anosmia, diarrhea, myalgia - symptoms less than 14 days - id physician determination that the patient does not need hospitalization - o2 saturation of >93% - informed consent provided by the patient or healthcare proxy - age ≥ 18 years - ambulatory outpatient when informed consent obtained and study drug is administered